search
Back to results

A Study of Comparing Effects of Thulium Laser en Bloc Resection and Electrical Transurethral Resection of the Non-muscle Invasive Bladder Cancer

Primary Purpose

Bladder Cancer

Status
Unknown status
Phase
Phase 3
Locations
Study Type
Interventional
Intervention
Thulium Laser en Bloc Resection of bladder tumor
Electrical transurethral resection of bladder tumor
Sponsored by
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Bladder Cancer

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)MaleDoes not accept healthy volunteers

Inclusion Criteria:

  1. Pathological or histological diagnosis of primary non-muscle invasive bladder urothelial carcinoma (TaTisT1);
  2. Imaging examinations showed the bladder muscle has not been affected, no lymph node metastasis or distant metastasis;
  3. Patients who agree to TURBT surgery, and will be effected to the postoperative follow-up treatment such as conventional infusion after the operation;
  4. Function of main organs (heart, liver, lung, kidney) should be normal, PS score 0-2;
  5. Bladder capacity≥ 200ml.

Exclusion Criteria:

  1. Find distant metastasis ,infiltration of the surrounding organs or relapse before operation.Metastatic bladder cancer or other cancers involve the bladder;
  2. Received chemotherapy or BCG perfusion therapy in the nearly 3 months;
  3. Patients who can not tolerate the serious side effects during the bladder perfusion treatment process (bladder irritation and other symptoms);
  4. Patients during pregnancy ,critical care patients and patients who have other cases of surgical contraindications.Such as serious cardiovascular disease,coagulation abnormalities,non-transitional epithelial tumors( such as adenocarcinoma and squamous cell carcinoma),acute cystitis,can not be supine because of spinal deformity,untreated urethral stricture.

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Experimental

    Active Comparator

    Arm Label

    Thulium Laser en Bloc Resection of bladder tumor

    Electrical transurethral resection of bladder tumor

    Arm Description

    Thulium Laser en Bloc Resection of the Non-muscle Invasive Bladder tumor with thulium laser

    Electrical transurethral resection of the Non-muscle Invasive Bladder tumor

    Outcomes

    Primary Outcome Measures

    The residual rate of tumor in the second operation of the two surgical methods

    Secondary Outcome Measures

    Full Information

    First Posted
    October 23, 2016
    Last Updated
    October 31, 2016
    Sponsor
    Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT02951078
    Brief Title
    A Study of Comparing Effects of Thulium Laser en Bloc Resection and Electrical Transurethral Resection of the Non-muscle Invasive Bladder Cancer
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    October 2016
    Overall Recruitment Status
    Unknown status
    Study Start Date
    January 2017 (undefined)
    Primary Completion Date
    December 2018 (Anticipated)
    Study Completion Date
    undefined (undefined)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

    4. Oversight

    5. Study Description

    Brief Summary
    This study is to verify the short-term efficacy and long-term prognosis of thulium laser resection compared with conventional transurethral resection of non-muscular invasive bladder cancer. Half of participants will receive thulium laser resection of bladder cancer, while the other half will receive electrical transurethral resection of bladder cancer.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Bladder Cancer

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Phase 3
    Interventional Study Model
    Parallel Assignment
    Masking
    InvestigatorOutcomes Assessor
    Allocation
    Randomized
    Enrollment
    172 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    Thulium Laser en Bloc Resection of bladder tumor
    Arm Type
    Experimental
    Arm Description
    Thulium Laser en Bloc Resection of the Non-muscle Invasive Bladder tumor with thulium laser
    Arm Title
    Electrical transurethral resection of bladder tumor
    Arm Type
    Active Comparator
    Arm Description
    Electrical transurethral resection of the Non-muscle Invasive Bladder tumor
    Intervention Type
    Procedure
    Intervention Name(s)
    Thulium Laser en Bloc Resection of bladder tumor
    Intervention Type
    Procedure
    Intervention Name(s)
    Electrical transurethral resection of bladder tumor
    Primary Outcome Measure Information:
    Title
    The residual rate of tumor in the second operation of the two surgical methods
    Time Frame
    2 years

    10. Eligibility

    Sex
    Male
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Pathological or histological diagnosis of primary non-muscle invasive bladder urothelial carcinoma (TaTisT1); Imaging examinations showed the bladder muscle has not been affected, no lymph node metastasis or distant metastasis; Patients who agree to TURBT surgery, and will be effected to the postoperative follow-up treatment such as conventional infusion after the operation; Function of main organs (heart, liver, lung, kidney) should be normal, PS score 0-2; Bladder capacity≥ 200ml. Exclusion Criteria: Find distant metastasis ,infiltration of the surrounding organs or relapse before operation.Metastatic bladder cancer or other cancers involve the bladder; Received chemotherapy or BCG perfusion therapy in the nearly 3 months; Patients who can not tolerate the serious side effects during the bladder perfusion treatment process (bladder irritation and other symptoms); Patients during pregnancy ,critical care patients and patients who have other cases of surgical contraindications.Such as serious cardiovascular disease,coagulation abnormalities,non-transitional epithelial tumors( such as adenocarcinoma and squamous cell carcinoma),acute cystitis,can not be supine because of spinal deformity,untreated urethral stricture.
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    Haitao Liu, chief physician
    Phone
    +86 15301655608
    Email
    doctorlht69@163.com

    12. IPD Sharing Statement

    Learn more about this trial

    A Study of Comparing Effects of Thulium Laser en Bloc Resection and Electrical Transurethral Resection of the Non-muscle Invasive Bladder Cancer

    We'll reach out to this number within 24 hrs